Guided Therapeutics (GTHP) Enterprise Value (2010 - 2026)
Guided Therapeutics (GTHP) posted Enterprise Value of -$63000.0 for Q4 2025, up 27.59% sequentially from -$87000.0 in Q3 2025, and up 83.76% YoY from -$34283.3 in Q4 2024.
Guided Therapeutics (GTHP) Enterprise Value (2010 - 2026) Analysis & Trends
Guided Therapeutics has reported Enterprise Value for 16 years, with the latest figure at -$63000.0 in Q4 2025.
- Quarterly Enterprise Value rose 83.76% year-over-year to -$63000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$63000.0 (up 83.76% YoY) and the FY2025 annual result came in at -$63000.0, up 83.76% from the prior year.
- Enterprise Value rose to -$63000.0 in Q4 2025 per GTHP's latest filing, from -$87000.0 in the prior quarter.
- Over five years, Enterprise Value peaked at -$63000.0 in Q4 2025 and troughed at -$2.7 million in Q3 2022.
- A 5-year average of -$790150.0 and a median of -$566000.0 in 2021 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2021 and 2025: Enterprise Value slumped 5838.1% in 2021, then jumped 83.76% in 2025.
- Over 5 years, Enterprise Value stood at -$643000.0 in 2021, then plunged by 259.72% to -$2.3 million in 2022, then soared by 74.45% to -$591000.0 in 2023, then soared by 34.35% to -$388000.0 in 2024, then surged by 83.76% to -$63000.0 in 2025.
- According to Business Quant data, Enterprise Value over the past three periods registered -$63000.0, -$87000.0, and -$185000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | -4.95 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | -3.48 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | -8.61 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | -297.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | -4.15 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | -1.95 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | -1.88 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | -3.29 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -467.80 Mn |
| 10 | Guided Therapeutics | 26.06 Mn | 26.05 Mn | - | -12,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -12,000.00 |
| Dec 31, 2025 | -63,000.00 |
| Sep 30, 2025 | -87,000.00 |
| Jun 30, 2025 | -185,000.00 |
| Mar 31, 2025 | -115,000.00 |
| Dec 31, 2024 | -388,000.00 |
| Sep 30, 2024 | -194,000.00 |
| Jun 30, 2024 | -275,000.00 |
| Mar 31, 2024 | -445,000.00 |
| Dec 31, 2023 | -591,000.00 |
| Sep 30, 2023 | -731,000.00 |
| Jun 30, 2023 | -1.36 Mn |
| Mar 31, 2023 | -1.84 Mn |
| Dec 31, 2022 | -2.31 Mn |
| Sep 30, 2022 | -2.70 Mn |
| Jun 30, 2022 | -446,000.00 |
| Mar 31, 2022 | -725,000.00 |
| Dec 31, 2021 | -643,000.00 |
| Sep 30, 2021 | -541,000.00 |
| Jun 30, 2021 | -922,000.00 |